Uranus Chemicals Co., LTD. (TPEX:7742)
38.25
+0.10 (0.26%)
At close: Feb 11, 2026
TPEX:7742 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 665.01 | 821.91 | 726.29 | 1,318 | 993.92 | |
Revenue Growth (YoY) | -21.54% | 13.17% | -44.88% | 32.58% | - |
Cost of Revenue | 608.96 | 642.23 | 552.79 | 1,054 | 884.33 |
Gross Profit | 56.05 | 179.68 | 173.5 | 264.22 | 109.59 |
Selling, General & Admin | 85.44 | 103.45 | 63.7 | 154.05 | 93.12 |
Research & Development | 10.08 | 7.45 | 4.53 | 7.74 | 3.83 |
Operating Expenses | 94.9 | 110.29 | 68.22 | 161.79 | 96.19 |
Operating Income | -38.85 | 69.39 | 105.27 | 102.43 | 13.4 |
Interest Expense | -21.08 | -11.72 | -8.93 | -7.94 | -7.13 |
Interest & Investment Income | 11.08 | 10.34 | 7.89 | 7.14 | 3.95 |
Currency Exchange Gain (Loss) | -52.82 | 30.51 | -0.23 | 8.47 | 0.49 |
Other Non Operating Income (Expenses) | -82.29 | 19.28 | 4.78 | 7.77 | 8.09 |
EBT Excluding Unusual Items | -183.95 | 117.79 | 108.78 | 117.87 | 18.8 |
Gain (Loss) on Sale of Investments | -32.3 | -6.74 | -3.17 | -86 | 230.63 |
Gain (Loss) on Sale of Assets | 0.15 | 0.39 | -0.48 | -0.24 | 0.02 |
Asset Writedown | -1.69 | -1.69 | - | - | -46.99 |
Other Unusual Items | - | - | - | -44.13 | -43.2 |
Pretax Income | -217.79 | 109.75 | 105.14 | -12.5 | 159.27 |
Income Tax Expense | 3.3 | 24.08 | 16.97 | 34.47 | -0.53 |
Net Income | -221.09 | 85.67 | 88.17 | -46.96 | 159.8 |
Preferred Dividends & Other Adjustments | - | - | -36.13 | -44.16 | -43.23 |
Net Income to Common | -221.09 | 85.67 | 124.3 | -2.81 | 203.02 |
Net Income Growth | - | -2.83% | - | - | - |
Shares Outstanding (Basic) | 66 | 66 | 62 | 58 | 54 |
Shares Outstanding (Diluted) | 66 | 67 | 62 | 58 | 54 |
Shares Change (YoY) | 2.93% | 6.68% | 8.31% | 6.14% | - |
EPS (Basic) | -3.33 | 1.29 | 2.00 | -0.05 | 3.75 |
EPS (Diluted) | -3.33 | 1.29 | 1.41 | -0.05 | 3.74 |
EPS Growth | - | -8.51% | - | - | - |
Free Cash Flow | -591.43 | -63.04 | -335.6 | -3.24 | 9.03 |
Free Cash Flow Per Share | -8.91 | -0.95 | -5.38 | -0.06 | 0.17 |
Dividend Per Share | 0.800 | 0.800 | 0.700 | 0.500 | 0.500 |
Dividend Growth | 14.29% | 14.29% | 40.00% | - | - |
Gross Margin | 8.43% | 21.86% | 23.89% | 20.05% | 11.03% |
Operating Margin | -5.84% | 8.44% | 14.49% | 7.77% | 1.35% |
Profit Margin | -33.25% | 10.42% | 17.11% | -0.21% | 20.43% |
Free Cash Flow Margin | -88.94% | -7.67% | -46.21% | -0.24% | 0.91% |
EBITDA | 44.7 | 156.58 | 182.07 | 161.11 | 65.46 |
EBITDA Margin | 6.72% | 19.05% | 25.07% | 12.23% | 6.59% |
D&A For EBITDA | 83.55 | 87.2 | 76.8 | 58.67 | 52.06 |
EBIT | -38.85 | 69.39 | 105.27 | 102.43 | 13.4 |
EBIT Margin | -5.84% | 8.44% | 14.49% | 7.77% | 1.35% |
Effective Tax Rate | - | 21.94% | 16.14% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.